moved:
Motion No. 4
That Bill C-9, in Clause 1, be amended by replacing line 23 on page 7 with the following:
“at least thirty days before filing the applica-”
Motion No. 5
That Bill C-9, in Clause 1, be amended by replacing, in the French version, lines 26 and 27 on page 7 with the following:
“l'OMC mentionné dans la demande, et ce à des conditions raisonnables et sans succès,”
Motion No. 6
That Bill C-9, in Clause 1, be amended by replacing lines 21 to 25 on page 11 with the following:
“its label and packaging, as required by regulations made under the Food and Drugs Act, as well as information identifying every known party that will be handling the product while it is in transit from Canada to the country or WTO Member to which it is to be exported.”
Motion No. 7
That Bill C-9, in Clause 1, be amended by replacing line 29 on page 11 with the following:
“(3) The Commissioner shall,”
Motion No. 8
That Bill C-9, in Clause 1, be amended by replacing line 34 on page 11 with the following:
“(4) The Commissioner shall,”
Motion No. 9
That Bill C-9, in Clause 1, be amended by replacing lines 1 to 3 on page 12 with the following:
“quantity to be exported, as well as every known party that will be handling the product while it is in transit from Canada to the country or WTO Member to which it is to be exported:”
Motion No. 10
That Bill C-9, in Clause 1, be amended by replacing lines 42 to 45 on page 15 with the following:
“authorized to be manufactured and sold, which agreement must incorporate information that is in all material respects identical to the information referred to in paragraphs 21.04(2)(a), (b), (e) and”
Motion No. 11
That Bill C-9, in Clause 1, be amended by replacing line 9 on page 18 with the following:
“Health shall establish, within three years after the day this section comes into force, an”